Before revision: Certolizumab pegol, sold under the brand name CIMZIA , is a biopharmaceutical medication for the treatment of Crohn's disease, rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.
After revision: Certolizumab pegol, sold under the brand name Cimzia , is a biopharmaceutical medication for the treatment of Crohn's disease, rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.